USFDA completes inspection of Dr Reddys' API Hyderabad Plant 3
Receives 5 observations under Form 483
Dr Reddys Laboratories announced that the audit of its API Hyderabad Plant 3 at Bollaram, Medak District, Telangana by the USFDA has been completed on 09 March 2018. The company has been issued a Form 483 with five observations.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 09 2018 | 6:11 PM IST